Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
12. März 2024 12:00 ET
|
Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004